Louis E. "Gene" Burton, PhD

Gene Burton, Ph.D., brings more than 22 years of biotechnology industry experience to DNA Bridges/Gateway International, Inc, working in various roles in biotechnology company management, in recombinant drug process and product development and as a seasoned protein chemist. Most recently, he was VP of Product Development and Process Sciences at Receptor BioLogix, Inc., a start up company in the oncology space working in the HER family system of receptors. Prior to the role at Receptor, he spent over 17 years at Genentech, Inc. and 5 years at Bayer Corporation, primarily focused on recombinant protein purification, process design and manufacturing implementation at scale, for pre-IND, IND and BLA drug candidates. He also helped direct the purification design and small-scale production of over 50 different research proteins as well as contributing to the development of two different drug screening programs. He was instrumental in the development program of a drug candidate from its inception to completion of Phase III, acting as the Project Team Leader, CMC team leader or its process development manager, over the course of the project's history.

In addition to his biotechnology experience, Dr. Burton served as an assistant professor and adjunct assistant professor at The Rockefeller University. He has had two postdoctoral experiences: at The Rockefeller with Dr. Stanford Moore, working with ribonuclease inhibitors, and at Stanford University with Dr. Eric Shooter, working with nerve growth factor. He is a member of the ASBMB, Society for Neuroscience and the AAAS, with more than 50 peer-reviewed publications and 5 patent applications or issues. Dr. Burton is a B.S. in Chemistry from Montana State University and a Ph.D. in Biochemistry from Michigan State University.